Are dendritic cells a potential tool for mastitis vaccine development?

Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F62156489%3A43210%2F23%3A43923000" target="_blank" >RIV/62156489:43210/23:43923000 - isvavai.cz</a>
Result on the web
<a href="https://doi.org/10.55251/jmbfs.9839" target="_blank" >https://doi.org/10.55251/jmbfs.9839</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.55251/jmbfs.9839" target="_blank" >10.55251/jmbfs.9839</a>

Result language
angličtina
Original language name
Are dendritic cells a potential tool for mastitis vaccine development?
Original language description
Mastitis is one of the main disease causing big economic losses to dairy farmers. This disease is caused mainly by bacteria. Because of not efficient vaccines, there are necessary to develop new immunotherapy of vaccination strategy to reduce this disease in dairy farms. Dendritic cells are antigen-presenting cells which are able to present antigen to lymphocytes. They are able to induce activation of T naïve lymphocytes. Dendritic cells were used for development of dendritic cell-based anti-tumor vaccines. Development of vaccines against bovine mastitis has many limitations as high number of various pathogens that are able to cause inflammation of mammary gland in cattle; absence of mucus barrier in mammary gland; reduced phagocytic efficiency because of casein and fat globules etc. To this day, it is not available vaccine against bovine mastitis with high efficiency. Development of new immunotherapy or vaccine against mastitis would be very desirable. In this mini review, we are considering possibilities for development of new dendritic cell-based vaccine against bovine mastitis.
Czech name
—
Czech description
—

Type
J<sub>imp</sub> - Article in a specialist periodical, which is included in the Web of Science database
CEP classification
—
OECD FORD branch
40201 - Animal and dairy science; (Animal biotechnology to be 4.4)

Project
<a href="/en/project/QK1910212" target="_blank" >QK1910212: Modern methods of diagnosis, therapy and prevention of mastitis caused by Streptococcus uberis as a tool for designing targeted control programs in cows</a><br>
Continuities
P - Projekt vyzkumu a vyvoje financovany z verejnych zdroju (s odkazem do CEP)

Publication year
2023
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Similar results(10)